Company
CITIUS ONCOLOGY, INC. (CTOR)
Standardized SEC financial data for CITIUS ONCOLOGY, INC. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001851484 · NASDAQ · Pharmaceutical Preparations.
Return on equity
-55.2%
Free cash flow
-$5.5M
Current ratio
0.56×
EPS (diluted)
$-0.34
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | — | — | $4.2M | — | $4.9M | $6.4M |
| SG&A expense |
Balance sheet
| USD | FY2022 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | $112 | $3.9M |
| Inventory |
Cash flow
| USD | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$48K | -$601K | $126K | -$5.5M |
| Investing cash flow | -$67.3M | -$1.3M | -$5.0M | -$5.8M |
Get CTOR data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/CTOR/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/CTOR/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"